Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: Gynecol Oncol. 2018 Aug 17;151(1):24–31. doi: 10.1016/j.ygyno.2018.08.014

Figure 1.

Figure 1.

(A) Progression-free survival and (B) overall survival stratified by residual disease. (C) Progression-free survival and (D) overall survival stratified by PDS-Year group.

CGR, residual disease 0 mm; Minimal residual, residual disease 1–10 mm; suboptimal, residual disease >10 mm

*Log-rank p value

**Chi-square p value at 5-year time point

PDS, primary debulking surgery; CGR, complete gross resection